GENEVA, Jan. 26 -- SHANGHAI SYMRAY BIOPHARMA INC. (Floor 7, Building 1, No. 58, Tanzhu RoadMinhang District, Shanghai 200241), 上海祥耀生物科技有限责任公司 (中国上海市闵行区潭竹路58号1幢701室) filed a patent application (PCT/CN2025/108874) for "ANTI-FXI ANTIBODY AND USE THEREOF" on Jul 16, 2025. With publication no. WO/2026/017079, the details related to the patent application was published on Jan 22, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization...